| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Article
Korean J Clin Oncol. 2012;8(1): 63-67.         doi: https://doi.org/10.14216/kjco.12009
Drug induced interstitial pneumonitis during FOLFOX4 chemotherapy for metastatic colorectal cancer
Jeung-seuk Yoon1, Dong-Guk Park1, Hwan Namgung1, Doh-hyung Kim2
1Department of Surgery, Division of Pulmonology and Allergy, Dankook University College of Medicine, Cheonan, Korea
2Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea
전이성 대장암에서 FOLFOX4 항암 화학요법 시행 중 발생한 간질성 폐질환 1예
윤정석1, 박동국1, 남궁환1, 김도형2
1단국대학교 의과대학 외과학 교실
2단국대학교 의과대학 내과학 교실
Corresponding Author: Hwan Namgung ,Tel: +82-41-550-3929, Fax: +82-41-556-3878, Email: gsnamgung@dankook.ac.kr
Received: March 29, 2012;  Accepted: June 18, 2012.
Share :  
FOLFOX4 regimen is one of the first line treatments for advanced colorectal cancer. Well known adverse effects are neurological, hematologic, and gastro-intestinal toxicities. But recently, there were several case reports about severe form pulmonary toxicity of this regimen. We herein report the case of an additional patient with FOLFOX4 induced interstitial lung disease.
Keywords: Colorectal cancer | FOLFOX4 | Interstitial lung disease
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : office@kjco.org

Copyright© Korean Society of Surgical Oncology.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers